1 / 69

Breast Mass

Breast Mass. Linda M. Barney M.D. Wright State University. Mrs. Trainor. Mrs. Trainor is a 57-year-old woman who was referred by her Gynecologist for evaluation of a breast mass. History. What other points of the history do you want to know?. Characterization of Symptoms :

chidi
Télécharger la présentation

Breast Mass

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Breast Mass Linda M. Barney M.D. Wright State University

  2. Mrs. Trainor • Mrs. Trainor is a 57-year-old woman who was referred by her Gynecologist for evaluation of a breast mass.

  3. History What other points of the history do you want to know?

  4. Characterization of Symptoms: Temporal sequence Alleviating / Exacerbating factors: Associated signs/symptoms Pertinent PMH ROS MEDS Relevant Family Hx. History, Mrs. TrainorConsider the following:

  5. Characterize Symptoms • 3 week history of left breast lump. • 1st noticed in the shower • Bean sized and nontender • May have increased in size slightly

  6. Associated Signs & Symptoms • Denies pain, skin change, nipple discharge • Prior history of Fibrocystic breasts, no biopsies • LMP 6 years ago • Last mammogram 11 months ago, routine mammography since 40’s • Denies trauma

  7. Pertinent PMH • Healthy, married, mother of 4 (3 girls 1 boy) • 1st pregnancy age 21, Breast fed 3 of 4 • Menarche age 11, OCP’s x 20 years total, • Menopause at 51, HRT w/ prempro x 7 years • Denies smoking, social alcohol only,no drugs • No chronic medical problems

  8. Aleviating/ Exacerbating factors • No change with activity • Uses Ibuprofen for headache with no change in the lump • Drinks decaffeinated tea and sodas only

  9. Family History • Maternal grandmother with breast cancer at age 62, maternal grandfather w/colon CA at 71 • Mother and sister with breast cancer, mother at age 52, Sister at 47 • 2 maternal aunts with ovarian cancer, 1 maternal uncle with colon cancer

  10. Differential DiagnosisBased on History and Presentation

  11. Differential DiagnosisConsider the following • Fibrocystic Mass • Breast Cancer • Fibroadenoma • Cyst • Fat necrosis

  12. Physical Examination What would you look for?

  13. Physical Examination, Mrs. Trainor Relevant Exam findings for a problem focused assessment Skin & Soft Tissue Breasts: Symmetrical, no skin changes, nipples everted/ no discharge. Right breast w/no dominant findings. Left breast with 1-2cm firm mass with ill-defined margins at 12’oclock, non-tender, Nodes: No axillary or supraclavicular nodes Chest: CTA ABD: No Hepatosplenomegaly or mass Genitorectal: Uterus retroflexed, no mass, no adnexal mass, guaiac – stool, no mass Extremities: No edema, Right-handed, neuro intact Remaining Examination findings non-contributory

  14. Studies What further studies would you want at this time?

  15. Studies, Mrs. Trainor

  16. Studies, Mrs. Trainor

  17. MammogramComparison CC View R L

  18. MammogramComparison MLO Views R L  Marker palpable

  19. US Breast L Breast

  20. Studies – Results • Focused L Breast US demonstrates a 1.7 cm poorly defined, heterogeneous, hypoechoic nodule, with abnormal shadowing • Taller than wide orientation(violates tissue planes) • No additional abnormalities are noted • Mammogram reveals a 1.8cm spiculated mass, upper central L breast corresponding to palpable abnormality. • Dense parenchyma with no other abnormalities What is the differential diagnosis at this point?

  21. Revised Differential Diagnosis • Breast Cancer • Fibrocytic Mass • Fat necrosis • Radial Scar • Fibroadenoma • Cyst

  22. Discuss Mrs. Trainor’s Breast Cancer Risk Factors Are there any tools to help determine her risk?

  23. NEGATIVE Menarche/Menopause? Hormone Exposure Family with 1st degree relatives w/ BCA Genetic predisposition profile? Age POSITIVE Menarche/Menopause? Parity Lactation Age at 1st pregnancy No hx. of at risk pathology Risk Factors Discuss Gail Model & other risk assessment options

  24. Laboratory What would you obtain?

  25. Lab Discussion • No labs indicated at this point • Patient has no clinical signs of infection and no suggestion of any systemic disease • Screening labs may be indicated for pre-op/ pre-treatment

  26. What next? • Additional Imaging? • Observation ? • Biopsy ? • OR? • Other?

  27. Observation • Not reasonable in a post-menopausal high risk patient with a suspicious palpable mass,abnormal imaging and a strong family history.

  28. Interventions at this point?

  29. Discuss options for tissue diagnosis

  30. Biopsy Techniques • Needle Core Biopsy • FNA • Excisional Biopsy • Image Guided Biopsy • Ultrasound • Stereotactic

  31. Biopsy Options • Which techniques are applicable for Mrs. Trainor? • What are the advantages/disadvantages of each? • What information is needed from the biopsy specimen?

  32. Biopsy Options • FNA is a minimally invasive technique best suited for clearly benign or clearly malignant lesions & less suited for indeterminate lesions. It provides small volume cellular material for cyto-pathologic diagnosis. • CORE BX is also minimally invasive, but provides a # of tissue cores for histo-pathologic diagnosis. Volume of specimen usually permits analysis of hormone receptors and Her-2-neu.

  33. Biopsy Options • Image guided technique can be utilized with FNA but is most often used with CORE needle biopsy. Appropriate for non-palpable lesions identified by either mammography or US (CT & MRI too) • A number of devices are available and enable consecutive biopsies, varying sizes, marker clip deployment & localization wire placement.

  34. US Directed Biopsy

  35. Pathology • Invasive Ductal Adenocarcinoma Grade II • ER+/PR+ Her2neu -

  36. What next?

  37. Treatment Considerations • Unilateral vs Bilateral Disease or Risk including genetic predisposition • Extent of Disease/ Clinical Stage • Comorbidities • Breast Conservation • Patient Preference***

  38. Surgical Treatment Options • Lumpectomy w/ SLN sampling +/-axillary dissection & post-op Radiation Therapy • Mastectomy w/ SLN sampling +/-axillary dissection +/- reconstruction • Modified Radical Mastectomy +/- reconstruction

  39. Breast Reconstruction Options Immediate • Staged Implant reconstruction/ tissue expander • TRAM Flap • Latissimus Dorsi Flap • Free Flaps Delayed • Staged Implant reconstruction/ tissue expander • TRAM Flap • Latissimus Dorsi Flap • Free Flaps

  40. Additional Treatment Considerations • Neoadjuvant Chemotherapy? • Adjuvant Chemotherapy? • Adjuvant Hormonal Therapy? • Ablative therapies? • Clinical Trials participation +/-

  41. Management What would you advise for Mrs. Trainor? • She wants to know more about Sentinel Lymph Node Sampling. • Can you explain how it’s done and how it works? • She’s leaning toward breast conservation surgerybut is worried the tumor might come back. • What would you tell her regarding her risk and prognosis? • Will pre-operative genetic testing influence her treatment decision?

  42. Discuss Surgical Risks & Potential Complications

  43. Risks & Expected Course • Anesthetic • Peri-operative • Medications • Antibiotic? • Lymphazurin reaction* • Incisions/ Dressings/ Drains • Need for re-excision for margins or nodes

  44. Complications • Wound Infection • Breast Lymphedema • Arm Lymphedema • Seroma/Hematoma • Nerve Injury • Flap Necrosis • Poor Cosmetic Result

  45. Treatment, Mrs.Trainor • She elects Lumpectomy w/ SLN sampling & post-op RT • Pre-op Chem profile, and Chest X-ray are NL • No metastatic imaging was performed • She decides NOT to pursue genetic testing • Final Pathology • 1.9cm Invasive Ductal GrII with minor component of DCIS • 3 SLN’s negative by H&E and IHC • ER+/PR+ Her2Neu-

  46. Pathology, Mrs. Trainor

  47. Stage & Prognosis • Mrs. Trainor comes back to the office for her 1st post-op visit, doing well with no post-operative issues. • Discuss her pathology, • Disease stage & prognosis • Any further treatment recommendations?

  48. Staging & Additional Treatment Stage 1 T1c pN0 M0 • Tumor >1cm <2cm, • Nodes – by IHC/H&E • No evidence of metastatic disease What Next? • Referral to medical oncologist for adjuvant therapy considerations • Referral to radiation oncologist for completion of post-op RT • Discuss long term follow-up recommendations

  49. What if your patient is: • A 41-year-old female with a 6 week history of generalized fullness of her right breast and skin dimpling. • Exam demonstrates a 5 cm irregular fixed right breast mass with skin dimpling and palpable R axillary nodes.

  50. Right Breast Skin Dimpling & Nipple Retraction

More Related